‘Ground-breaking’ research on inflammatory disease treatment set to be commercialised
The new research by Heriot-Watt University has identified a way of targeting an enzyme called EPAC1
Read More
Tag: Inflammatory disease
Janssen inks inflammatory disease collaboration with Mestag Therapeutics
Collaboration will utilise Mestag’s specialist fibroblast subpopulation biology platform to identify novel therapeutic targets
Read More
C4X Discovery agrees licensing deal with Sanofi
Sanofi could pay up to €414m for C4X Discovery’s oral IL-17A inhibitor programme
Read More
Roche acquires Irish biotech firm Inflazome
Swiss pharma company to acquire biotech for $449m (€380m)
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
